Xu Cynthia, Sellke Frank W, Abid M Ruhul
Cardiovascular Research Center, Rhode Island Hospital, Providence, Rhode Island.
Division of Cardiothoracic Surgery, Alpert Medical School of Brown University and Rhode Island Hospital, Providence, Rhode Island.
Am J Physiol Heart Circ Physiol. 2022 Jun 1;322(6):H891-H905. doi: 10.1152/ajpheart.00589.2021. Epub 2022 Mar 25.
Microvascular disease plays critical roles in the dysfunction of all organ systems, and there are many methods available to assess the microvasculature. These methods can either assess the target organ directly or assess an easily accessible organ such as the skin or retina so that inferences can be extrapolated to the other systems and/or related diseases. Despite the abundance of exploratory research on some of these modalities and their possible applications, there is a general lack of clinical use. This deficiency is likely due to two main reasons: the need for standardization of protocols to establish a role in clinical practice or the lack of therapies targeted toward microvascular dysfunction. Also, there remain some questions to be answered about the coronary microvasculature, as it is complex, heterogeneous, and difficult to visualize in vivo even with advanced imaging technology. This review will discuss novel approaches that are being used to assess microvasculature health in several key organ systems, and evaluate their clinical utility and scope for further development.
微血管疾病在所有器官系统功能障碍中起关键作用,并且有许多方法可用于评估微血管系统。这些方法既可以直接评估靶器官,也可以评估诸如皮肤或视网膜等易于检查的器官,以便可以推断到其他系统和/或相关疾病。尽管对其中一些方法及其可能的应用进行了大量探索性研究,但普遍缺乏临床应用。这种不足可能主要归因于两个原因:需要标准化方案以在临床实践中确立作用,或者缺乏针对微血管功能障碍的治疗方法。此外,关于冠状动脉微血管系统仍有一些问题有待解答,因为它复杂、异质性强,即使使用先进的成像技术也难以在体内可视化。本综述将讨论用于评估几个关键器官系统中微血管健康的新方法,并评估其临床实用性和进一步发展的空间。